These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 304000)
21. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage. Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246 [TBL] [Abstract][Full Text] [Related]
22. Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes. Fuson EW; Shaw MW; Hubbard RA; Lamon EW Clin Exp Immunol; 1979 Oct; 38(1):158-65. PubMed ID: 316751 [TBL] [Abstract][Full Text] [Related]
23. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity. Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314 [TBL] [Abstract][Full Text] [Related]
24. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. Aramburu J; Balboa MA; Izquierdo M; López-Botet M J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia. Romanski A; Bug G; Becker S; Kampfmann M; Seifried E; Hoelzer D; Ottmann OG; Tonn T Exp Hematol; 2005 Mar; 33(3):344-52. PubMed ID: 15730858 [TBL] [Abstract][Full Text] [Related]
27. Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering. Platsoucas CD Eur J Immunol; 1984 Jun; 14(6):566-77. PubMed ID: 6610558 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy. Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562 [TBL] [Abstract][Full Text] [Related]
29. Reconstitution of natural cell-mediated cytotoxicity with specific antibodies. Takasugi J; Koide Y; Takasugi M Eur J Immunol; 1977 Dec; 7(12):887-92. PubMed ID: 75804 [TBL] [Abstract][Full Text] [Related]
30. B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation. Storkus WJ; Dawson JR J Immunol; 1986 Mar; 136(5):1542-7. PubMed ID: 3081629 [TBL] [Abstract][Full Text] [Related]
31. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects. Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275 [TBL] [Abstract][Full Text] [Related]
32. Activation of Lyt-2+ T cells by antibodies towards brain-associated antigens. II. Antibody-dependent induction of "nonspecific" cell-mediated cytotoxicity. Gullberg M; Coutinho A Eur J Immunol; 1985 Oct; 15(10):971-6. PubMed ID: 3876942 [TBL] [Abstract][Full Text] [Related]
33. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus. Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188 [TBL] [Abstract][Full Text] [Related]
34. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes. Fan J; Bonavida B J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189 [TBL] [Abstract][Full Text] [Related]
35. Hyperthermic enhancement of antibody-complement cytotoxicity against normal mouse B lymphocytes and its relation to capping. Sultan MF; Tompkins WA; Cain CA Radiat Res; 1983 Nov; 96(2):251-60. PubMed ID: 6359237 [TBL] [Abstract][Full Text] [Related]
36. Anti-idiotype antibodies to the 9.1C3 blocking antibody used to probe the lethal hit stage of NK cell-mediated cytolysis. Werkmeister JA; Burns GF; Triglia T J Immunol; 1984 Sep; 133(3):1385-90. PubMed ID: 6611373 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of cell-mediated lysis by xenoantibodies reactive with effector T lymphocytes. Rabinowitz R; Laskov R; Schlesinger M Eur J Immunol; 1980 Mar; 10(3):219-23. PubMed ID: 6155273 [TBL] [Abstract][Full Text] [Related]
38. Antibody-mediated cell cytotoxicity in a defined system: regulation by antigen, antibody, and complement. Lustig HJ; Bianco C J Immunol; 1976 Jan; 116(1):253-60. PubMed ID: 1245741 [TBL] [Abstract][Full Text] [Related]
39. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells. Santoli D; Trinchieri G; Koprowski H J Immunol; 1978 Aug; 121(2):532-8. PubMed ID: 150448 [TBL] [Abstract][Full Text] [Related]
40. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell. Melewicz FM; Shore SL; Ades EW; Phillips DJ J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]